Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/14317
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorOLIVEIRA, Lilia A. M. L. de-
dc.contributor.authorBRIZOT, Maria L.-
dc.contributor.authorLIAO, Adolfo W.-
dc.contributor.authorBITTAR, Roberto E.-
dc.contributor.authorFRANCISCO, Rossana P. V.-
dc.contributor.authorZUGAIB, Marcelo-
dc.date.accessioned2016-07-18T12:18:47Z-
dc.date.available2016-07-18T12:18:47Z-
dc.date.issued2016-
dc.identifier.citationACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, v.95, n.4, p.436-443, 2016-
dc.identifier.issn0001-6349-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/14317-
dc.description.abstractIntroductionA previous study indicated that progesterone reduces the mean uterine contraction frequency in singleton pregnancy at high risk for preterm birth. The aim of this study was to investigate the effect of vaginal progesterone on the frequency of uterine contractions in twin pregnancies. Material and methodsThis was a secondary analysis of a randomized, double-blind, placebo-controlled trial of twin pregnancies exposed to vaginal progesterone or placebo. Naturally conceived twin pregnancies with no prior history of preterm delivery, asymptomatic regarding preterm labor, who had undergone uterine contraction frequency monitoring from 24 to 34 weeks and 6 days were included in the study. Comparison of the mean frequency of uterine contractions between the treatment groups was performed. We also examined the influence of cervical length and chorionicity on the mean frequency of uterine contractions according to the group. ResultsThe final analysis included 166 women in the progesterone and 170 in the placebo group. The baseline characteristics were similar in the two groups. Overall, no difference in the mean frequency of uterine contractions (p = 0.91) was observed between the progesterone (2.54 3.19) and placebo (2.56 +/- 3.59) groups. Also, no difference in the mean frequency of uterine contractions was observed between the groups in each week between 24 and 34 weeks and 6 days of gestation. Cervical length and chorionicity did not influence the frequency of contractions according to the progesterone or placebo treatment. ConclusionsOverall, progesterone does not influence the frequency of uterine contractions in twin pregnancies.-
dc.language.isoeng-
dc.publisherWILEY-BLACKWELL-
dc.relation.ispartofActa Obstetricia et Gynecologica Scandinavica-
dc.rightsrestrictedAccess-
dc.subjectTwin pregnancy-
dc.subjectcontraction frequency-
dc.subjectprogesterone-
dc.subjectuterine contraction monitoring-
dc.subjecttocodynamometry-
dc.subject.otherpreterm birth-
dc.subject.otherdouble-blind-
dc.subject.othercervical length-
dc.subject.otherprevention-
dc.subject.otherwomen-
dc.subject.otherlabor-
dc.subject.othertrial-
dc.subject.othermetaanalysis-
dc.subject.othermulticenter-
dc.subject.otherultrasound-
dc.titlePrenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies-
dc.typearticle-
dc.rights.holderCopyright WILEY-BLACKWELL-
dc.identifier.doi10.1111/aogs.12843-
dc.identifier.pmid26669629-
dc.subject.wosObstetrics & Gynecology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage436-
hcfmusp.description.endpage443-
hcfmusp.description.issue4-
hcfmusp.description.volume95-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84960798382-
hcfmusp.origem.idWOS:000372654300009-
hcfmusp.publisher.cityHOBOKEN-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAdams Waldorf KM, 2015, AM J OBSTET GYNECOL, V213, pe9-
hcfmusp.relation.referenceNorman JE, 2011, REPROD SCI, V18, P435, DOI 10.1177/1933719110395404-
hcfmusp.relation.referenceRode L, 2012, OBSTET GYNECOL, V120, P60, DOI 10.1097/AOG.0b013e31825bc3cd-
hcfmusp.relation.referenceda Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41-
hcfmusp.relation.referenceNorman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8-
hcfmusp.relation.referenceRomero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816-
hcfmusp.relation.referenceHack KEA, 2006, TWIN RES HUM GENET, V9, P450, DOI 10.1375/183242706777591281-
hcfmusp.relation.referenceMendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016-
hcfmusp.relation.referenceSchuit E, 2015, BJOG-INT J OBSTET GY, V122, P27, DOI 10.1111/1471-0528.13032-
hcfmusp.relation.referenceSerra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x-
hcfmusp.relation.referenceLei K, 2011, J CLIN ENDOCR METAB, V96, pE1013, DOI 10.1210/jc.2010-2310-
hcfmusp.relation.referenceBerghella V, 2004, AM J OBSTET GYNECOL, V191, P1253, DOI 10.1016/j.ajog.2004.03.012-
hcfmusp.relation.referenceChauhan SP, 2010, AM J OBSTET GYNECOL, V203, P305, DOI 10.1016/j.ajog.2010.04.031-
hcfmusp.relation.referenceLewis D, 2001, AM J OBSTET GYNECOL, V185, pS144, DOI 10.1016/S0002-9378(01)80263-5-
hcfmusp.relation.referenceNewman RB, 2006, AM J OBSTET GYNECOL, V195, P1564, DOI 10.1016/j.ajog.2006.03.063-
hcfmusp.relation.referenceHeath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x-
hcfmusp.relation.referencePerni SC, 2005, AM J OBSTET GYNECOL, V193, P942, DOI 10.1016/j.ajog.2005.05.081-
hcfmusp.relation.referenceRode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093-
hcfmusp.relation.referenceFujita MM, 2002, ACTA OBSTET GYN SCAN, V81, P856, DOI 10.1034/j.1600-0412.2002.810910.x-
hcfmusp.relation.referenceKELLY RW, 1994, HUM REPROD, V9, P253-
hcfmusp.relation.referenceNEWMAN RB, 1989, OBSTET GYNECOL, V73, P695-
hcfmusp.relation.referenceGarfield RE, 1998, HUM REPROD UPDATE, V4, P673, DOI 10.1093/humupd/4.5.673-
hcfmusp.relation.referenceNEWMAN RB, 1986, AM J OBSTET GYNECOL, V154, P530-
hcfmusp.relation.referenceRouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641-
hcfmusp.relation.referenceBrizot ML, 2015, AM J OBSTET GYNECOL, V213-
hcfmusp.relation.referenceLewi L, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.009-
hcfmusp.relation.referenceNewman R. B., 1997, Acta Geneticae Medicae et Gemellologiae, V46, P1-
hcfmusp.relation.referenceNorusis MJ, 2012, IBM SPSS STAT 19 ADV-
hcfmusp.relation.referenceRomero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/J.AJ0G.2011.12.003-
dc.description.indexMEDLINE-
dc.identifier.eissn1600-0412-
hcfmusp.citation.scopus6-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/57
LIM/57 - Laboratório de Fisiologia Obstétrica


Files in This Item:
File Description SizeFormat 
art_OLIVEIRA_Prenatal_administration_of_vaginal_progesterone_and_frequency_of_2016.PDF
  Restricted Access
publishedVersion (English)281.15 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.